Clinical Trials Directory

Trials / Completed

CompletedNCT01318018

Investigation on the Value of Bilateral Index (BIS) Monitoring for Magnetic Seizure Versus Electroconvulsive Therapy

Bilateral Bispectral Index Monitoring During and After Electroconvulsive Therapy Compared With Magnetic Seizure Therapy for Treatment-resistant Depression

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
University Hospital, Bonn · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Electroconvulsive therapy (ECT) has been shown to be an effective treatment for patients suffering from depression, who do not respond to medical treatment. However it is often dismissed by patients, who feel uncomfortably about the application of electric shocks to their heads. In 2000, magnetic seizure therapy (MST) has been introduced which uses magnetism instead of electricity to evoke convulsions. MST seems to be as effective as ECT in terms of its antidepressant potency but may be associated with less severe cognitive side effects. Control of anaesthesia during seizure therapy is demanding since light anesthesia might be associated with awareness, whereas deep anesthesia impedes the antidepressant effect of the convulsion. Therefore, Bispectral index (BIS) monitoring is frequently used to tailor anaesthesia for ECT, however little is known about BIS following MST. The investigators hypothesize that in comparing MST with ECT, (a) patients show a faster increase in BIS and that (b)less left-right differences occur in BIS.

Conditions

Timeline

Start date
2011-02-01
Primary completion
2011-12-01
Completion
2012-02-01
First posted
2011-03-18
Last updated
2018-10-05
Results posted
2018-10-05

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01318018. Inclusion in this directory is not an endorsement.